Delivery Order SPE2DB24D1205-SPE2DB24FCTDF

Award Date 7/26/24
Potential Completion Date 7/29/24
Potential Value $24K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is valued at $13,128.09 and is for the delivery of GARDASIL 9 syringes, a vaccine product. The contract has a firm fixed price pricing type and an ultimate completion date of August 9, 2024. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous federal contracts by the DLA and other agencies to supply a variety of...
This delivery order contract, valued at $8,569.49, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. The contract has a completion date of September 23, 2024 and is structured as a firm fixed price arrangement. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple federal contracts and Indefinite Delivery...
This is a delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $24,574.24 firm fixed price contract is for the supply of GARDASIL 9 vaccine syringes. The contract has an ultimate completion date of April 18, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025,...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for the supply of GARDASIL 9 syringes, a vaccine medication, with a potential value of $3,181.05. The order has a completion date of March 5, 2024 and was awarded on March 4, 2024. Amerisourcebergen Drug Corp holds an...
This is a $27,366.39 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of GARDASIL 9 vaccine syringes. The contract has an ultimate completion date of August 1, 2024 and is not set aside for any special categories of contractors. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies for the provision of a wide range...
This is a $10,784.33 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Medical Supply Chain to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is for the delivery of GARDASIL 9 SYRINGE 0.5ML and has an ultimate completion date of April 29, 2024. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,568.50 firm fixed price contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. The contract has an ultimate completion date of September 26, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of medical commodities, including critical care...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor. The $9,950.72 firm-fixed-price contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. The contract has an ultimate completion date of August 27, 2024 and is not a set-aside award. Amerisourcebergen is a large supplier of pharmaceuticals and medical supplies to various federal agencies and healthcare...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $76,416.04 firm fixed price contract is for the supply of GARDASIL 9 syringes, a vaccine product, with an ultimate completion date of August 21, 2024. The contract is not set aside for any small business designation. AmerisourceBergen is one of the largest pharmaceutical distributors in the U.S. and has numerous indefinite delivery contracts (IDCs) with federal...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the delivery of GARDASIL 9 vaccine syringes, with a potential value of $6,533.07 and a completion date of February 1, 2024. Amerisourcebergen Drug Corp has a history of providing pharmaceuticals, medical supplies, and distribution...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB24FCTDF
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of GARDASIL 9 syringes, a vaccine product, valued at $23,928.34 and has a completion date of July 29, 2024. The contract is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen is a major pharmaceutical distributor that holds several indefinite delivery contracts with the DLA and other federal agencies, through which it provides a wide range of medical commodities, including prescription drugs, vaccines, and medical supplies, to support military treatment facilities, veterans' healthcare programs, and other government healthcare initiatives.

Generated 10/25/24, 9:10 AM